723 related articles for article (PubMed ID: 30716508)
1. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
[TBL] [Abstract][Full Text] [Related]
2. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Yebyo HG; Aschmann HE; Puhan MA
Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
6. Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials.
Hou Q; Chen Y; Zhang Y; Pang C
Cardiovasc Drugs Ther; 2024 Jun; 38(3):459-469. PubMed ID: 36447018
[TBL] [Abstract][Full Text] [Related]
7. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
8. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
[TBL] [Abstract][Full Text] [Related]
9. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
[TBL] [Abstract][Full Text] [Related]
10. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
[TBL] [Abstract][Full Text] [Related]
11. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
Esmeijer K; Dekkers OM; de Fijter JW; Dekker FW; Hoogeveen EK
Sci Rep; 2019 Nov; 9(1):16632. PubMed ID: 31719617
[TBL] [Abstract][Full Text] [Related]
12. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
[TBL] [Abstract][Full Text] [Related]
13. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Naci H; Brugts J; Ades T
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis.
Zhong P; Wu D; Ye X; Wu Y; Li T; Tong S; Liu X
Drug Des Devel Ther; 2017; 11():2517-2526. PubMed ID: 28919704
[TBL] [Abstract][Full Text] [Related]
15. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults.
Zhou Z; Curtis AJ; Ernst ME; Ryan J; Zoungas S; Wolfe R; McNeil JJ; Murray AM; Reid CM; Chowdhury EK; Woods RL; Tonkin AM; Nelson MR
Eur J Clin Pharmacol; 2022 Mar; 78(3):467-476. PubMed ID: 34698889
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.
Hoang T; Kim J
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722395
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
Lu Y; Cheng Z; Zhao Y; Chang X; Chan C; Bai Y; Cheng N
Atherosclerosis; 2016 Nov; 254():215-227. PubMed ID: 27764723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
